Cargando…
Inhibition of the TGFβ signalling pathway by cGMP and cGMP‐dependent kinase I in renal fibrosis
Agents that enhance production of nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) ameliorate the progression of renal fibrosis. However, the molecular mechanism of this process is not fully understood. We hypothesize that the antifibrotic effects of cGMP and cGMP‐dependent kinase I (cGKI...
Autores principales: | Schinner, Elisabeth, Wetzl, Veronika, Schramm, Andrea, Kees, Frieder, Sandner, Peter, Stasch, Johannes‐Peter, Hofmann, Franz, Schlossmann, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377407/ https://www.ncbi.nlm.nih.gov/pubmed/28396839 http://dx.doi.org/10.1002/2211-5463.12202 |
Ejemplares similares
-
Suppression of kidney fibrosis by cGMP-dependent protein kinase I
por: Schinner, Elisabeth, et al.
Publicado: (2013) -
NO/cGMP signalling in platelets
por: Schinner, Elisabeth, et al.
Publicado: (2009) -
Suppression of kidney fibrosis by cGMP-dependent protein kinase I
por: Schinner, Elisabeth, et al.
Publicado: (2011) -
cGMP becomes a drug target
por: Schlossmann, Jens, et al.
Publicado: (2012) -
Vascular and renal function of cGMP signalling
por: Schlossmann, Jens, et al.
Publicado: (2011)